New TB drug regimen controls resistant disease in 9 of 10 cases: study

(Reuters Health) - The new anti-tuberculosis drug combination of bedaquiline, pretomanid and linezolid cures 90% of people with deadly drug-resistant TB if given for six months, researchers report in The New England Journal of Medicine.

Source: Reuters: Health - March 5, 2020 Category: Consumer Health News Tags: healthNews Source Type: news